Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Long COVID can cause anemia and iron issues, leading to fatigue and slow recovery, especially in men and severe cases.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

Low testosterone levels may lead to more severe COVID-19 outcomes.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Long COVID is a big health problem needing more research and better treatments.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Long COVID can cause long-lasting symptoms, but vaccination and early treatment can help prevent it.

Health workers in non-COVID wards had higher depression and anxiety rates.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

More research is needed to understand sex and racial differences in long COVID.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Asthma and high testosterone increase Covid-19 severity, while progesterone protects young women.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Genetic differences affect how people respond to COVID-19.